Advertisement

Remission Realized: Achieving Disease Control in Your Patients with Rheumatoid Arthritis - Episode 4

Complications and Prognostic Factors in Uncontrolled Rheumatoid Arthritis

Published on: 
, , , ,

A panel of medical experts discuss complications and prognostic factors in uncontrolled rheumatoid arthritis.

EP. 1: Intro and Welcomes
EP. 2: Evolving Goals in Rheumatoid Arthritis Treatment: Defining and Achieving Clinical Remission
EP. 3: Prevalence and Management of Poorly Controlled Rheumatoid Arthritis in Clinical Practice
Now Viewing
EP. 4: Complications and Prognostic Factors in Uncontrolled Rheumatoid Arthritis
EP. 5: Evaluating and Adjusting Rheumatoid Arthritis Treatment: Adhering to ACR Guidelines for csDMARDs and Advanced Therapies
EP. 6: Exploring the Discrepancy Between Patient Perception and Disease Activity Assessments
EP. 7: Achieving Low Disease Activity and Remission: Managing Patient Expectations
EP. 8: Guidance on Transitioning from TNFi to Non-TNF Targeted Therapies
EP. 9: Advanced Treatment Options for RA: Exploring the Data
EP. 10: Guiding Treatment Decisions: The Role of Remission Data and Head-to-Head Comparisons
EP. 11: JAK Inhibitors vs TNF Inhibitors: Effects on Administration, Efficacy, and Safety
EP. 12: JAK Inhibitor Selectivity and Dose-Related Toxicity

Video content above is prompted by the following:

What are typical complications associated with uncontrolled rheumatoid arthritis?

Are there patient prognostic factors that can help determine likelihood of uncontrolled disease vs remission?

Related Content:

Video SeriesClinicalPeer ExchangeRheumatoid Arthritis
Research Identifies Potential Markers for ASCVD Risk in People With Rheumatoid Arthritis
JAK Inhibitor Selectivity and Dose-Related Toxicity
JAK Inhibitors vs TNF Inhibitors: Effects on Administration, Efficacy, and Safety
Advertisement
Advertisement